In Massachusetts, GenePeeks, Inc. has a new President and Chief Commercial Officer, Matt Posard, who comes with over 25 years of experience at a variety of genomic and life sciences companies including Illumina, Inc., Trovagene, Inc. and Alere, Inc. His role at GenePeeks will be to head up commercialization of their computational genomics products and services. Their patented Virtual Progeny Analytics product takes the genetic makeup of two parents and computationally predicts what diseases or health issues their child will be at risk for, genetically speaking, before they even conceive a baby. Many parents want to know the risks before they conceive, especially for serious diseases, so they can be more prepared for the possibilities.
Latest article
World Animal Protection launches AI-Powered cultivated meat chatbot
In London, animal advocacy group World Animal Protection has partnered with AI software company PubTrawlr to unveil Cultivator, the first-ever chatbot dedicated to cultivated...
DOE awards Hempitecture $8.42 million to boost hemp fiber manufacturing in Tennessee
In Idaho, sustainable building materials firm Hempitecture has been awarded $8.42 million in funding from the U.S. Department of Energy under the Biden-Harris Administration’s...
CJ Biomaterials PHA earns compostability certification
In Massachusetts, CJ Biomaterials, a division of South Korea's CJ CheilJedang, has received certification from the Biodegradable Products Institute (BPI) for its range of...